Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study

1. del Barco Morillo, E.
2. Mesía, R.
3. Adansa Klain, J.C.
4. Vázquez Fernández, S.
5. Martínez-Galán, J.
6. Pastor Borgoñon, M.
7. González-Rivas, C.
8. Caballero Daroqui, J.
9. Berrocal, A.
10. Martínez-Trufero, J.
11. Vera, R.
12. Cruz-Hernández, J.J.